PeptideDB

DHPS-IN-1 2643300-54-1

DHPS-IN-1 2643300-54-1

CAS No.: 2643300-54-1

DHPS-IN-1 has the best DHPS inhibitory potency (IC50 = 0.014 μM) and excellent inhibitory activity against melanoma cel
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

DHPS-IN-1 has the best DHPS inhibitory potency (IC50 = 0.014 μM) and excellent inhibitory activity against melanoma cells.

Physicochemical Properties


Molecular Formula C17H13BRCLN3O2
Molecular Weight 406.661021947861
Exact Mass 404.99
CAS # 2643300-54-1
PubChem CID 156704958
Appearance Solid powder
LogP 4.7
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 4
Heavy Atom Count 24
Complexity 398
Defined Atom Stereocenter Count 0
SMILES

BrC1C=CC(=CC=1)C1N=C(C(=C(N)N=1)OC1C=CC=CC=1OC)Cl

InChi Key GBTXLCFBIYCONW-UHFFFAOYSA-N
InChi Code

InChI=1S/C17H13BrClN3O2/c1-23-12-4-2-3-5-13(12)24-14-15(19)21-17(22-16(14)20)10-6-8-11(18)9-7-10/h2-9H,1H3,(H2,20,21,22)
Chemical Name

2-(4-bromophenyl)-6-chloro-5-(2-methoxyphenoxy)pyrimidin-4-amine
Synonyms

DHPS-IN-1
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: (1). This product requires protection from light (avoid light exposure) during transportation and storage.(2). Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Novel Allosteric Inhibitors of Deoxyhypusine Synthase against Malignant Melanoma: Design, Synthesis, and Biological Evaluation. J Med Chem. 2021 Sep 23;64(18):13356-13372.


Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~245.91 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (6.15 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (6.15 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.4591 mL 12.2953 mL 24.5906 mL
5 mM 0.4918 mL 2.4591 mL 4.9181 mL
10 mM 0.2459 mL 1.2295 mL 2.4591 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.